Healthcare Services

IntelliCyt Corporation

9620 San Mateo Blvd
Albuquerque, NM 87113 USA
Click for website

Research Sector Healthcare Services

Summary Description Develops cell and bead-based screening solutions for use in phenotypic drug discovery, antibody discovery and in vitro toxicity testing.

Management R. Terry Dunlay, Founder, President and CEO; Thomas Duensing, Ph.D., Chief Technology Officer; Janette Phi, Chief Commercial Officer; Dennis Hynson, Chief Financial Officer

Click here for Financial Data
Keywords: cell, screenings, bead, antibody, in vitro toxicity testing


Updated: Oct. 23, 2015


Develops, manufactures and markets high-thoroughput, high content cell and bead-based screening systems based on flow cytometry technology. Their products address pervasive need among pharmaceutical......view more

Products / Services

iQue ForeCyt IntelliCyt Data Manager (IDM) MultiCyt Assay Kit HyperCyt......view more

Technology / Differentiation

Integrated screening platform includes: iQue Screener instrument, ForeCyt screening software, IntelliCyt Data Manager (iDM) informatics software, and MultiCyt Assay Kit reagents iQue Screener util...view more

Market / Customers

Biotechnology, Pharmaceutical, Academic & Government Labs The US, Europe and Japan account for 86% of the global flow cytometry market, but the market share held by Brazil, Russia, India and China ......view more

Competitors / Substitutes / Alternatives

BD Biosciences, Beckman Coulter Inc., accounting for a combined 49% of the global flow cytometry market Focusing on developing flow cytometry reagents: AbD Serotec, ALPCO, Apogee Flow, Bay, BioCyte...view more

Revenue / Funding

Funding to Date: $13.3 million funding to date Financing Sought: Seeking Strategic Partner(s)...view more